Home › Idiopathic Pulmonary Fibrosis › Kansas
Idiopathic Pulmonary Fibrosis clinical trials in Kansas
7 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Kansas.
Cities in Kansas
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- The University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Kansas City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- The University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- University of Kansas, Kansas City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT05571059WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Kansas City, KS, Kansas City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805Interstitial Lung Disease Research Unit Biobank
- The University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05392881From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.